Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

What are Cells?01:07

What are Cells?

201.2K
Cells are the smallest and basic units of life, whether it is a single cell that forms the entire organism, e.g., in a bacterium or trillions of them, e.g., in humans. No matter what organism a cell is a part of, they share specific characteristics.
Basic Characteristics of Cells
A living cell has a plasma membrane, a bilayer of lipids that separates the aqueous solution inside the cell called the cytoplasm from the outside environment.
Furthermore, a living cell possesses genetic information...
201.2K
What are Cells?01:15

What are Cells?

49.1K
Cells are the smallest and basic units of life, whether it is a single cell that forms the entire organism, e.g., in a bacterium, or trillions of them, e.g., in humans. No matter what organism a cell is a part of, they share specific characteristics.
Basic Characteristics of Cells
A living cell has a plasma membrane, a bilayer of lipids that separates the aqueous solution inside the cell called the cytoplasm from the outside environment.
Furthermore, a living cell possesses genetic information...
49.1K
What is Cell Signaling?02:03

What is Cell Signaling?

130.9K
Despite the protective membrane that separates a cell from the environment, cells need the ability to detect and respond to environmental changes. Additionally, cells often need to communicate with one another. Unicellular and multicellular organisms use a variety of cell signaling mechanisms to communicate to respond to the environment.
130.9K
Chemistry of the Cell02:58

Chemistry of the Cell

48.1K
The cell is chemically composed of water, organic molecules and inorganic ions.
Water
The polarity of the water molecule and its resulting hydrogen bonding makes water a unique substance with special properties that are intimately tied to the processes of life. Life originally evolved in an aqueous environment, and most of an organism’s cellular chemistry and metabolism occur inside the aqueous contents of the cell’s cytoplasm. Special properties of water are its high heat capacity...
48.1K
Concentration Cells02:41

Concentration Cells

25.9K
A concentration cell is a type of a  voltaic cell constructed by connecting two almost identical half-cells, both based on the same half-reaction and using the same electrode, differing only in the concentration of one redox species. A concentration cell's potential, therefore, is determined only by the concentration difference of the particular redox species.
Consider the following voltaic cell:
25.9K
Cell Size01:22

Cell Size

128.6K
Cell sizes vary widely among and within organisms. Bacterial cells range between 1-10 micrometers (μm)and are considerably smaller than most eukaryotic cells. The smallest bacteria are 0.1 μm in diameter—about a thousand times smaller than eukaryotic cells, which typically range from 10-100 μm.
Surface Area
Cells can take in nutrients and water via diffusion through the plasma membrane itself or through specific channels in the membrane. The area of the membrane surrounding...
128.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasticity under pressure: biology and detection of lineage switch in acute leukemia.

Leukemia·2026
Same author

CD19/CD22 bivalent CAR T cells in children, adolescents and young adults with B-ALL: final phase 1 trial results.

Journal for immunotherapy of cancer·2026
Same author

CRISPR-Cas9 CD33-deleted allogeneic hematopoietic cell transplantation with gemtuzumab ozogamicin maintenance in AML: a phase 1/2 trial.

Nature medicine·2026
Same author

How I treat HLH-like toxicities after immune effector cell therapy.

Blood·2026
Same author

CRLF2 rearrangement and extramedullary disease in B-cell acute lymphoblastic leukemia: a possible link?

Blood advances·2026
Same author

CD19 CAR T-cell outcomes in relapsed/refractory extramedullary B-ALL: a multisite, retrospective cohort review.

Blood advances·2026

Related Experiment Video

Updated: Feb 6, 2026

Studying Interactions between Myeloid Cells and CAR T Cells In Vitro and In Vivo
05:14

Studying Interactions between Myeloid Cells and CAR T Cells In Vitro and In Vivo

Published on: July 25, 2025

890

Seeing Is Believing: IEC-HS after CAR T Cells.

Joseph M Rocco1, Nirali N Shah2

  • 1National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.

Blood Cancer Discovery
|February 4, 2026
PubMed
Summary

Immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome (IEC-HS) is a CAR T-cell therapy complication. A specific cytokine trio (IFNγ, IL10, IL1RA) strongly correlates with IEC-HS severity, aiding early intervention strategies.

More Related Videos

A Spheroid Killing Assay by CAR T Cells
08:19

A Spheroid Killing Assay by CAR T Cells

Published on: December 12, 2018

17.2K
Production of Human CRISPR-Engineered CAR-T Cells
06:33

Production of Human CRISPR-Engineered CAR-T Cells

Published on: March 15, 2021

14.6K

Related Experiment Videos

Last Updated: Feb 6, 2026

Studying Interactions between Myeloid Cells and CAR T Cells In Vitro and In Vivo
05:14

Studying Interactions between Myeloid Cells and CAR T Cells In Vitro and In Vivo

Published on: July 25, 2025

890
A Spheroid Killing Assay by CAR T Cells
08:19

A Spheroid Killing Assay by CAR T Cells

Published on: December 12, 2018

17.2K
Production of Human CRISPR-Engineered CAR-T Cells
06:33

Production of Human CRISPR-Engineered CAR-T Cells

Published on: March 15, 2021

14.6K

Area of Science:

  • Immunology
  • Oncology
  • Cell Therapy

Background:

  • Immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome (IEC-HS) is a serious complication following chimeric antigen receptor (CAR) T-cell therapy.
  • IEC-HS occurs more frequently with CD22- or BCMA-targeted CAR T-cells compared to CD19-targeted constructs.

Purpose of the Study:

  • To investigate the relationship between CAR T-cell expansion, cytokine profiles, and the development and severity of IEC-HS.
  • To identify specific biomarkers that can predict or indicate the severity of IEC-HS for guiding preemptive interventions.

Main Methods:

  • Analysis of patient data from CAR T-cell therapy trials.
  • Measurement of CAR T-cell expansion and serum cytokine levels (including IFNγ, IL10, and IL1RA).
  • Correlation analysis between cytokine levels, CAR T-cell expansion, and IEC-HS incidence and severity.

Main Results:

  • Higher CAR T-cell expansion was associated with IEC-HS.
  • A unique cytokine profile was observed in patients with IEC-HS.
  • The combination of IFNγ, IL10, and IL1RA showed the strongest correlation with IEC-HS severity.

Conclusions:

  • IEC-HS is a significant concern in CAR T-cell therapy, particularly with CD22/BCMA targeting.
  • Specific cytokine signatures, especially IFNγ, IL10, and IL1RA, are key indicators of IEC-HS severity.
  • These cytokine biomarkers may facilitate early detection and preemptive management of IEC-HS in patients undergoing CAR T-cell therapy.